Medlinker is based in Chengdu, China. It has raised $842M in total funding. Latest round: Series E.
Medlinker funding overview
Medlinker is based in Chengdu, China. Medlinker has raised $842M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series E announced in December 2021. The round record for Medlinker runs through 2021; nothing later has been disclosed. Investors on record include China Investment Corp (CIC), Sequoia Capital, China Renaissance, Tencent, FY Capital, Sino Biopharmaceutical. 6 distinct backers are named across the disclosed rounds.
Medlinker at a glance
Total raised
$842M
Latest round
Series E
Latest round date
December 2021
Headquarters
Chengdu, China
Notable investors
China Investment Corp (CIC), Sequoia Capital, China Renaissance, Tencent, FY Capital, Sino Biopharmaceutical
Frequently asked about Medlinker funding
How much has Medlinker raised?
Medlinker has raised $842M in total disclosed funding across the rounds on record.
Who has invested in Medlinker?
China Investment Corp (CIC), Sequoia Capital, China Renaissance, Tencent, FY Capital, Sino Biopharmaceutical are named among the investors backing Medlinker.
What was the latest Medlinker funding round?
The most recent disclosed round is a Series E, announced in December 2021.
Where is Medlinker based?
Medlinker is based in Chengdu, China.
When did Medlinker last raise?
The last disclosed Medlinker round closed in December 2021 at Series E.
Medlinker totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Chengdu below to benchmark round size and investor mix.
